Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Modern HIV treatment offers remarkable outcomes. This guide explores essential first steps, treatment advances, support ...

The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

On these fronts, the situation with bird flu in California is improving since its height in December 2024 when Gov. Gavin ...

Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...